791 results on '"Lenz, H-J"'
Search Results
2. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
3. Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
4. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
5. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
6. Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer
7. Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis
8. CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy
9. Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
10. Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases
11. Genetic variants associated with colorectal brain metastases susceptibility and survival
12. Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer
13. Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
14. 397P Early decreases in KRAS mutant allele frequency (MAF) predicts clinical benefit to the PLK1 inhibitor onvansertib in combination with FOLFIRI/bev in 2L treatment of metastatic colorectal carcinoma (mCRC)
15. 1402P Initial results of a cohort of advanced prostate cancer patients in a phase Ia study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody
16. Molekulare Diagnostik und Response-Prädiktion
17. Pharmacogenomics and Colorectal Cancer
18. Pharmakogenetik
19. Möglichkeiten der Response Prediction
20. Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer
21. Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases
22. Supplement of Information: Data Integration by Classification of Pairs of Records
23. Controlling Based on Stochastic Models
24. On the Solution of Fuzzy Equation Systems
25. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy
26. Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer
27. Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
28. KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
29. Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer
30. On the Non-Robustness of Maximum-Likelihood Sampling Plans by Variables
31. GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients
32. A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
33. Operative Controlling Based on Bayesian Networks Using the Kalman Filter Technique
34. Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
35. Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence
36. Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy
37. The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy
38. Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen
39. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
40. Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials
41. On the Design of Exact Single Sampling Plans by Variables
42. Statistical Quality Control of Data
43. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma
44. Controlling unter Unsicherheit
45. 550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors
46. 454P CCR5/CCL5 gene expression in colorectal cancer (CRC): Comprehensive profiling and clinical value
47. LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy
48. Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer
49. PD-025 RECOURSE trial: impact of adverse events on quality of life and duration of TAS-102 (trifluridine and tipiracil) treatment
50. O-026 Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC): phase 2 results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.